The Journal of Stem Cell Biology and Regenerative Sciences (JSCBRS) is an international, peer-reviewed, open-access scholarly journal dedicated to advancing research and innovation in the fields of stem cell biology, regenerative medicine, and translational sciences. The journal provides a global platform for researchers, clinicians, academicians, and industry professionals to publish high-quality research that enhances the understanding and application of stem cells in tissue repair, disease treatment, and broader biomedical advancements. JSCBRS is committed to maintaining the highest standards of publication ethics and scientific integrity, following internationally recognized guidelines such as COPE and ICMJE, while promoting transparency in peer review, reproducibility of research, and the dissemination of scientifically sound and impactful findings.

The journal aims to promote high-quality research, support the global exchange of innovative scientific knowledge, and encourage collaboration between basic scientists and clinicians. It focuses on advancing translational research that bridges laboratory discoveries with real-world clinical applications, contributing to developments in personalized medicine and tissue engineering while ensuring ethical and transparent publishing practices. By fostering interdisciplinary collaboration, JSCBRS seeks to bridge the gap between fundamental research and clinical practice, supporting innovations that have the potential to transform healthcare and improve patient outcomes worldwide.

The journal welcomes original research articles, review articles, case studies, short communications, and technical reports across a wide range of areas including stem cell biology, such as embryonic, adult, and induced pluripotent stem cells, along with stem cell signaling, differentiation, and microenvironment studies; regenerative medicine, including tissue engineering, biomaterials, organ regeneration, cell-based therapies, gene editing technologies like CRISPR, and regenerative immunology; as well as translational and clinical research covering clinical trials, stem cell transplantation, regenerative approaches for chronic diseases, and neurological and cardiovascular regeneration. In addition, the journal covers emerging and interdisciplinary areas such as bioengineering, nanotechnology, artificial organs, 3D bioprinting, systems biology, computational modeling, aging research, and cancer stem cells. Supporting disciplines including molecular and cellular biology, biotechnology, bioinformatics, pharmacological approaches in regeneration, and the ethical, legal, and social aspects of stem cell research are also within the scope of the journal.